Clarivate stock rating reiterated at Sector Perform by RBC Capital

RBC Capital reiterated its Sector Perform rating and $6.00 price target for Clarivate (CLVT), citing potential upside in Life Sciences revenue and robust operational performance, including 75% A&G subscription renewals and over 50% IPfolio customer growth. This outlook contrasts with the company's recent Q2 results, which saw revenue exceed expectations but an unexpected loss of $0.11 per share, alongside a 17.5% year-to-date stock underperformance and a new 'Peerperform' rating from Wolfe Research, despite InvestingPro data suggesting the stock is currently undervalued.

Analysis

Clarivate Plc (CLVT) presents a conflicting financial profile, characterized by strong operational metrics offset by a significant recent profitability miss. On one hand, RBC Capital highlights positive underlying trends, including the renewal of 75% of the Academia & Government division's 2025 subscription base, a more than 50% year-over-year increase in IPfolio's new customer base, and benefits from transitioning products to a subscription model. Despite this operational momentum and a second-quarter revenue of $621.4 million that surpassed the $587.36 million consensus, the company reported an unexpected loss of $0.11 per share, starkly contrasting with analyst expectations for a $0.17 profit. This failure to translate top-line growth into bottom-line results appears to be a key driver of negative sentiment, reflected in the stock's 17.5% year-to-date decline. The market's caution is further underscored by Wolfe Research's new 'Peerperform' rating and a modest $4-$5 fair value range, suggesting that while the stock appears undervalued at $3.84 relative to some analyst targets, significant execution risk is being priced in.

Key Decisions for Investors

• Investors should weigh the positive operational leading indicators, such as strong subscription renewals and customer growth in key segments, against the company's significant second-quarter earnings miss, which signals a potential disconnect between revenue generation and profitability.
• Given that RBC Capital expects Clarivate to maintain its fiscal year 2025 guidance, the next earnings report is critical; monitor for any improvement in profit margins to validate that the recent earnings loss was an anomaly and not a systemic issue.
• Considering the stock's 17.5% year-to-date underperformance and the new neutral 'Peerperform' rating from Wolfe Research, a cautious stance is warranted until management demonstrates a clear path to converting revenue beats into sustainable profit.